First, an experiment of optical clearing using a tissue optical clearing agent was designed to assess the efficiency of sonophoresis with ultrasound contrast agents. Two types of experiment were designed to quantitatively evaluate the efficiency of transdermal drug delivery according to ultrasound contrast agent concentration.

In the present study, we addressed the dependence of ultrasound contrast agent concentration using two types of drug on the efficiency of transdermal drug delivery. Furthermore, the mutual interactions of microbubble determined by concentration of added bubble are also thought to be an important factor for activity of stable cavitation, even in different characteristics of drug. Actively-induced cavitation with low-intensity ultrasound (less than ~1 MPa) causes disordering of the lipid bilayers and the formation of aqueous channels by stable cavitation which indicates a continuous oscillation of bubbles. It is to utilize the engineered microbubble and its resonant frequency for increase of cavitation activity. Recently, a new logical approach to enhance the efficiency of transdermal drug delivery was tried. Cavitation is recognized as the predominant mechanism of sonophoresis. Sonophoresis can increase skin permeability to various drugs in transdermal drug delivery.

Flaticon commercial use